110 related articles for article (PubMed ID: 17524)
21. Decarbonylation: A metabolic pathway of cannabidiol in humans.
Kraemer M; Broecker S; Madea B; Hess C
Drug Test Anal; 2019 Jul; 11(7):957-967. PubMed ID: 30698361
[TBL] [Abstract][Full Text] [Related]
22. Microsomal metabolism of the 1",1"-dimethylheptyl analogue of cannabidiol: relative percentage of monohydroxy metabolites in four species.
Samara E; Brown NK; Harvey DJ
Drug Metab Dispos; 1990; 18(4):548-9. PubMed ID: 1976083
[No Abstract] [Full Text] [Related]
23. Identification of six substituted 4''-hydroxy-metabolites of of delta1-tetrahydrocannabinol in mouse liver.
Harvey DJ; Paton WD
Res Commun Chem Pathol Pharmacol; 1978 Sep; 21(3):435-46. PubMed ID: 705022
[TBL] [Abstract][Full Text] [Related]
24. Identification of monohydroxylated metabolites of cannabidiol formed by rat liver.
Martin B; Nordqvist M; Agurell S; Lindgren JE; Leander K; Binder M
J Pharm Pharmacol; 1976 Apr; 28(4):275-9. PubMed ID: 6714
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of (+)-trans-delta 8-tetrahydrocannabinol in the mouse in vitro and in vivo.
Harvey DJ; Marriage HJ
Drug Metab Dispos; 1987; 15(6):914-20. PubMed ID: 2893721
[TBL] [Abstract][Full Text] [Related]
26. Analysis of di-n-butylphthalate biotransformation in cattle by liquid chromatography/ion trap mass spectrometry/mass spectrometry.
Coldham NG; Dave M; Sauer MJ
J Mass Spectrom; 1998 Sep; 33(9):803-10. PubMed ID: 9768498
[TBL] [Abstract][Full Text] [Related]
27. Chemical synthesis and biological occurrence of carboxylic acid metabolites of delta1(6)-tetrahydrocannabinol.
Agurell S; Edward C; Halldin M; Leander K; Levy S; Lindgren JE; Mechoulam R; Noreqvist M; Ohlsson A
Drug Metab Dispos; 1979; 7(3):155-61. PubMed ID: 38086
[TBL] [Abstract][Full Text] [Related]
28. Selective inactivation of mouse liver cytochrome P-450IIIA by cannabidiol.
Bornheim LM; Correia MA
Mol Pharmacol; 1990 Sep; 38(3):319-26. PubMed ID: 2402224
[TBL] [Abstract][Full Text] [Related]
29. Identification of the metabolites of erythro-9-(2-hydroxy-3-nonyl)hypoxanthine from laboratory animals.
Pfadenhauer EH; Bankert CS; Jensen J; Jones CE; Jenkins EE; McCloskey JA
Drug Metab Dispos; 1984; 12(3):280-4. PubMed ID: 6145553
[TBL] [Abstract][Full Text] [Related]
30. Characterization of mephenytoin metabolites in human urine by gas chromatography and mass spectrometry.
Lynn RK; Bauer JE; Gordon WP; Smith RG; Griffin D; Thompson RM; Jenkins R; Gerber N
Drug Metab Dispos; 1979; 7(3):138-44. PubMed ID: 38083
[TBL] [Abstract][Full Text] [Related]
31. Characterization of glucuronide metabolites of carbamazepine in human urine by gas chromatography and mass spectrometry.
Lynn RK; Smith RG; Thompson RM; Deinzer ML; Griffin D; Gerber N
Drug Metab Dispos; 1978; 6(4):494-501. PubMed ID: 28932
[TBL] [Abstract][Full Text] [Related]
32. Identification of human hepatic cytochrome p450 enzymes involved in the biotransformation of cholic and chenodeoxycholic acid.
Deo AK; Bandiera SM
Drug Metab Dispos; 2008 Oct; 36(10):1983-91. PubMed ID: 18583509
[TBL] [Abstract][Full Text] [Related]
33. In vivo biotransformation of 17 alpha-methyltestosterone in the horse revisited: identification of 17-hydroxymethyl metabolites in equine urine by capillary gas chromatography/mass spectrometry.
Dumasia MC
Rapid Commun Mass Spectrom; 2003; 17(4):320-9. PubMed ID: 12569442
[TBL] [Abstract][Full Text] [Related]
34. In vivo biotransformation of metoprolol in the horse and on-column esterification of the aminocarboxylic acid metabolite by alcohols during solid phase extraction using mixed mode columns.
Dumasia MC
J Pharm Biomed Anal; 2006 Jan; 40(1):75-81. PubMed ID: 16168607
[TBL] [Abstract][Full Text] [Related]
35. Identification of glucose conjugates as major urinary metabolites of cannabidiol in the dog.
Samara E; Bialer M; Harvey DJ
Xenobiotica; 1990 Feb; 20(2):177-83. PubMed ID: 2333714
[TBL] [Abstract][Full Text] [Related]
36. 5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid.
Massi P; Valenti M; Vaccani A; Gasperi V; Perletti G; Marras E; Fezza F; Maccarrone M; Parolaro D
J Neurochem; 2008 Feb; 104(4):1091-100. PubMed ID: 18028339
[TBL] [Abstract][Full Text] [Related]
37. Urinary metabolites of delta 1-tetrahydrocannabinol in man.
Halldin MM; Carlsson S; Kanter SL; Widman M; Agurell S
Arzneimittelforschung; 1982; 32(7):764-8. PubMed ID: 6289845
[TBL] [Abstract][Full Text] [Related]
38. Determination of n-hexane metabolites by liquid chromatography/mass spectrometry. 2. Glucuronide-conjugated metabolites in untreated urine samples by electrospray ionization.
Manini P; Andreoli R; Mutti A; Bergamaschi E; Niessen WM
Rapid Commun Mass Spectrom; 1998; 12(21):1615-24. PubMed ID: 9807835
[TBL] [Abstract][Full Text] [Related]
39. Metabolism of the antianxiety drug buspirone in the rat.
Jajoo HK; Mayol RF; LaBudde JA; Blair IA
Drug Metab Dispos; 1989; 17(6):625-33. PubMed ID: 2575498
[TBL] [Abstract][Full Text] [Related]
40. Identification of cannabielsoin, a new metabolite of cannabidiol formed by guinea-pig hepatic microsomal enzymes, and its pharmacological activity in mice.
Yamamoto I; Gohda H; Narimatsu S; Yoshimura H
J Pharmacobiodyn; 1988 Dec; 11(12):833-8. PubMed ID: 3254981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
